Limited benefit: Studies of bumetanide have not significantly reduced autism characteristics, but some researchers are unwilling to give up the drug. Sergey / Adobe Stock Two phase 3 clinical trials of the diuretic bumetanide were canceled by their sponsors on September 7 after preliminary data showed the drug did no better than a placebo in […]
This article was originally published here Syst Rev. July 20, 2021; 10 (1): 207. doi: 10.1186 / s13643-021-01757-8. ABSTRACT BACKGROUND: Children’s academic readiness has important implications for later achievement and psychosocial functioning. A growing number of studies are using randomized controlled trials (RCTs) to investigate whether responsive parental interventions lead to positive increases in children’s […]
This article was originally published here Syst Rev. July 20, 2021; 10 (1): 207. doi: 10.1186 / s13643-021-01757-8. ABSTRACT BACKGROUND: Children’s academic readiness has important implications for later achievement and psychosocial functioning. A growing number of studies are using randomized controlled trials (RCTs) to investigate whether responsive parental interventions lead to positive increases in children’s […]
